DERMHAGE products provide safe and long-lasting results for patients while utilising groundbreaking and patented Smooth Rheology Hyaluronic Acid (SRHA) technology. SHRA technology preserves the natural qualities of pure HA and combined with a premium syringe improves safety and control for practitioners, guaranteeing a smooth, precise and homogeneous application.
There are four products in the range with varying molecular weights, allowing practitioners to offer a bespoke treatment plan for patients of all genders, ages, skin types and with a range of concerns:
- 20mg/ml HA concentration
- For soft tissue correction and fine lines including crows’ feet, tear troughs, acne scarring, stretch marks, and smokers’ lines.
- Depth of injection: between dermal and epidermal layers, superficial to supraperiostal.
- Injection techniques: papula or micro-papula, threading, blanching.
- Effect duration: 6 to 9 months
- Clinical trials have proven DERMHAGE fillers best resemble Juvederm and Restylane
- DERMHAGE fillers are available at a more commercial price
Key Features:
- Patented SHRA technology
- Lab tested and found to resemble Juvederm and Restylane
- Class III Medical Device with CE Mark 0483 and ISO 13485
- Designed and made in the EU using pure French HA
- Low extrusion force
- Premium syringe for better safety, control and comfort
- Extra precision with visual graduation
- 1 x 1ml per unit
- Includes 2 x thin 27G x ½” Terumo needles
- 36-month shelf life
- Immediately visible results with excellent product projection
Dermhage Must Not Be Used In:
- People under the age of 18
- Women who are pregnant or breastfeeding
- Patients who are known to have a sensitivity to hyaluronic acid
- Immediately before or post chemical peeling, laser therapy or dermabrasion
- Areas presenting signs of infection or cutaneous inflammation
- Patients who tend to develop hypertrophic scarring
